Addison Advisors’s Neuronetics STIM Stock Holding History

Addison Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,000	Closed	-$4.35K	–	970
2026 Q1	$4.35K	Hold	3,000	–	–	﹤0.01%	747
2025 Q4	$4.14K	Hold	3,000	–	–	﹤0.01%	715
2025 Q3	$8.19K	Hold	3,000	–	–	﹤0.01%	652
2025 Q2	$10.5K	Hold	3,000	–	–	﹤0.01%	613
2025 Q1	$11K	Hold	3,000	–	–	﹤0.01%	567
2024 Q4	$4.83K	Hold	3,000	–	–	﹤0.01%	678
2024 Q3	$2.28K	Hold	3,000	–	–	﹤0.01%	730
2024 Q2	$5.4K	Hold	3,000	–	–	﹤0.01%	627
2024 Q1	$14.3K	Hold	3,000	–	–	﹤0.01%	493
2023 Q4	$8.7K	Hold	3,000	–	–	﹤0.01%	528
2023 Q3	$4.05K	Hold	3,000	–	–	﹤0.01%	555
2023 Q2	$6.45K	Hold	3,000	–	–	﹤0.01%	517
2023 Q1	$8.73K	Hold	3,000	–	–	﹤0.01%	472
2022 Q4	$20.6K	Hold	3,000	–	–	0.01%	376
2022 Q3	$10K	Hold	3,000	–	–	0.01%	451
2022 Q2	$10K	Hold	3,000	–	–	0.01%	444
2022 Q1	$9K	Hold	3,000	–	–	﹤0.01%	493
2021 Q4	$13K	Hold	3,000	–	–	0.01%	387
2021 Q3	$20K	Buy	+3,000	New	+$28.8K	0.02%	260

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Addison Advisors's STIM Position: Q2 2026 in Review

Addison Advisors sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 3,000 shares — an estimated $4.35K sold.

Addison Advisors first reported a position in STIM in Q3 2021 and held it in 19 quarters. The position peaked at $20.6K in Q4 2022. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Addison Advisors reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
Addison Advisors sold 3,000 Neuronetics shares in Q2 2026, an estimated $4.35K.
Addison Advisors first reported a position in Neuronetics in Q3 2021 and held it in 19 quarters.
Addison Advisors's Neuronetics position peaked at $20.6K in Q4 2022.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.